Treatment for Fibromyalgia

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Swing Therapeutics, San Francisco, CA
Fibromyalgia+1 More
Eligibility
18+
All Sexes
Eligible conditions
Select

Study Summary

This study is evaluating whether a digital therapy can improve fibromyalgia symptoms.

See full description

Eligible Conditions

  • Fibromyalgia

Treatment Effectiveness

Effectiveness Estimate

1 of 3

Study Objectives

This trial is evaluating whether Treatment will improve 1 primary outcome and 9 secondary outcomes in patients with Fibromyalgia. Measurement will happen over the course of Baseline to Week 12.

Baseline to Week 12
Participant's self-reported average weekly pain interference score, recorded on an NRS scale
Participant's self-reported average weekly pain score, recorded on an NRS scale
Participant's self-reported weekly sleep interference score, recorded on an NRS scale
Revised Fibromyalgia Impact Questionnaire (FIQ-R) function domain score
Revised Fibromyalgia Impact Questionnaire (FIQ-R) impact domain score
Revised Fibromyalgia Impact Questionnaire (FIQ-R) symptoms domain score
Revised Fibromyalgia Impact Questionnaire (FIQ-R) total score
Week 12
Patient Global Impression of Change (PGIC) Response
Weeks 1-12
Participant's compliance with the Digital ACT device
Participant's engagement with the Digital ACT device

Trial Safety

Safety Estimate

1 of 3

Trial Design

0 Treatment Group

This trial requires 500 total participants across 0 different treatment group

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: weeks 1-12
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly weeks 1-12 for reporting.

Closest Location

Swing Therapeutics - San Francisco, CA

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 4 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
The participant can read and understand English, and they have consented to participate by signing electronically. show original
Key
Participants are at least 22 years old. show original
The person has a fibromyalgia diagnosis based on their self-reported responses to the 2016 American College of Rheumatology criteria for a fibromyalgia diagnosis. show original

Patient Q&A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Fibromyalgia by sharing your contact details with the study coordinator.